Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lok Beta Pharmaceuticals (India) Private Limited is an established Indian pharmaceutical company founded in 2002 and headquartered in Mumbai, Maharashtra. The company specializes in the development, manufacturing, and export of a wide range of generic formulations, including tablets, capsules, liquid orals, ointments, and active pharmaceutical ingredients (APIs). Its diverse therapeutic portfolio spans antiretrovirals, immunosuppressants, antibacterials, anti-diabetics, cardiovascular drugs, and gastrointestinal treatments. Lok Beta operates a WHO-GMP and EAEU-GMP approved manufacturing facility in Thane, Maharashtra, and exports its products to over 20 countries worldwide, with a strong marketing presence in Russia, Ukraine, Belarus, and other CIS nations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lok Beta Pharmaceuticals.